Last updated on July 2015

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation | Venous Thromboembolism
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other:
    Age ≥ 18 years
    Managed in view of surgery or an invasive procedure, emergency or not
    Managed and hospitalized for active bleeding
    Long-term therapy (in the indication atrial fibrillation or treatment of pulmonary
    embolism or deep vein thrombosis) by at least one antithrombotic agent from the
    following list: DABIGATRAN ETEXILATE MESYLATE or RIVAROXABAN or APIXABAN

You may not be eligible for this study if the following are true:

  • Pregnant women
    Refusal to participate in the study: listed in the non-inclusion registry
    Antithrombotics indicated for the prevention of venous thromboembolism

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.